Using two coils of magnetic stimulation to measure and modulate brain inhibition after stroke
Official title: Using Dual-coil Transcranial Magnetic Stimulation to Measure and Modulate Poststroke Interhemispheric Inhibition (IHI): A Concurrent TMS-EEG-EMG Study
Run by The Hong Kong Polytechnic University · NCT07431749 · Data updated 2026-11-12
This study tests a new TMS-EEG method to measure interhemispheric inhibition after stroke and compares it with the standard TMS-EMG method in stroke patients and healthy controls, plus explores how ccPAS with different timing affects that inhibition.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | The Hong Kong Polytechnic University Academic / other |
| Locations | 2 sites (Hong Kong and 1 other locations) |
| Status | Recruiting |
| Started | July 15, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | June 1, 2029 |
| Registry record updated | August 24, 2026 |
| Trial ID | NCT07431749 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 years who have had a stroke (≥6 months ago) with some residual upper limb function and evocable MEPs from both motor areas, able to consent and communicate in Chinese.
✕Probably not a fit
Stroke survivors who do not have evocable MEPs, have substantial cognitive impairment, or have contraindications to TMS may not benefit from this intervention strategy.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project has two parts. First, it will test the reliability of a novel TMS-EEG-based interhemispheric inhibition measure and compare it to the established TMS-EMG method in stroke patients and healthy controls, with a repeat session after one week. Second, it will use a randomized-crossover design where stroke patients receive a single session of dual-coil ccPAS at three different interstimulus intervals to see how LTD-like, LTP-like, and sham protocols modulate the TMS-EEG IHI marker. The study aims to understand whether this noninvasive brain stimulation approach can reliably characterize and influence interhemispheric communication after stroke. Participants will undergo MRI verification of lesion location and repeated neurophysiological assessments to evaluate changes in cortical inhibition. Safety considerations follow standard TMS guidelines for stroke survivors. The Hong Kong Polytechnic University leads the study with no listed external collaborators.
Why it matters
Potential benefit: If successful, this approach could provide a reliable, noninvasive way to measure and potentially enhance post-stroke brain recovery by modulating interhemispheric inhibition.
How similar studies have gone: Previous ccPAS and TMS-EEG studies suggest potential modulatory effects on cortical circuits, but the combined reliability validation against TMS-EMG in post-stroke IHI is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * (1) have a diagnosis of ischemic or hemorrhagic stroke, with time after stroke onset≥6 months. For stroke patients, we will invite participants to receive a structural magnetic resonance imaging (MRI) at the University Research Facility in Behavioral and Systems Neuroscience to verify their actual lesion location; (2) aged between 18 and 80 years old; (3) with residual upper limb functions from 4-7 levels in the Functional Test for the Hemiplegic Upper Extremity (Hong Kong version); (4) have evocable MEP from both M1; (5) able to give informed written consent to participate in the study. (6) able to understand and communicate with Chinese. Exclusion Criteria: (1) any contraindications to TMS (screened by the safety checklist by Rossi); (2) any concomitant neurological disease; (3) any sign of moderate-to-severe cognitive problems, i.e., the abbreviated mental test Hong Kong version\<6 out of 10 points \[22\]; and (4) Modified Ashworth score\>2 in hand, wrist or elbow extensor muscle in their hemiparetic upper limbs. In addition, a group of right-hand-dominant healthy adults, without any known neurological and psychiatric diseases, will be enrolled.
Where it's running
-
Hong Kong Polytechnic University
Hong Kong, Hong Kong Recruiting -
The Hong Kong Polytechnic University
Hong Kong, Hong Kong Not yet recruiting
Study contacts
- Study coordinator: JIAQI JACK Zhang, PhD
- Email: jack-jiaqi.zhang@polyu.edu.hk
- Phone: 27666696
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reactive Balance Training with Augmented Reality for Older Adults
This study tests whether reactive balance training using augmented reality helps older adults who are at risk of falling, compared with regular treadmill walking.
-
Mental imagery with self-regulation to help daily activities in Parkinson's disease
This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.
-
Lycium barbarum polysaccharide for dry eye symptoms in adults
Adults with dry eye disease will try taking Lycium barbarum polysaccharide tablets twice daily for 12 weeks to see if their symptoms and eye tests improve and to check safety.
-
LiFE-SePBT: A Friendly Balance Program to Help Older Adults Stay Steady at Home
We’re testing whether a light, lifestyle-based balance exercise program with small perturbations can improve balance for older adults who are at risk of falling.
-
Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness
This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.
-
Insomnia and Sleep Disruption's Effect on Pain Sensitivity and Muscle Soreness After Exercise
This study tests whether poor sleep or insomnia affects how people feel pain and recover from exercise-induced muscle soreness in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.